Name: | Procyclidine |
---|---|
PubChem Compound ID: | 207837 |
Description: | A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism. |
Molecular formula: | C19H30ClNO |
Molecular weight: | 323.9 g/mol |
Synonyms: |
1-Pyrrolidinepropanol, alpha-cyclohexyl-alpha-phenyl-, hydrochloride, (-)-; (-)-alpha-Cyclohexyl-alpha-phenyl-1-pyrrolidinepropanol hydrochloride; 30953-82-3; (-)-Procyclidine hydrochloride
|
Name: | Procyclidine |
---|---|
Name (isomeric): | DB00387 |
Drug Type: | small molecule |
Description: | A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism. |
Synonyms: |
Prociclidina [INN-Spanish]; Procyclidinum [INN-Latin]
|
Brand: | Kemadrine, Elorine, Metanin, Procyclid, Prosyklidin, Kemadrin, Spamol, Triciloid, Procyklidin, Vagosin, Tricoloid, Arpicolin, Tricyclamol, Triciclidina, Osnervan, Lergine |
Category: | Muscarinic Antagonists, Antidyskinetics, Antiparkinson Agents |
CAS number: | 77-37-2 |
Indication: | For the treatment of all forms of Parkinson's Disease, as well as control of extrapyramidal reactions induced by antipsychotic agents. |
---|---|
Pharmacology: | Procyclidine has an atropine-like action on parasympathetic-innervated peripheral structures including smooth muscle. It's antispasmodic effects are thought to be related to the blockage of central cholinergic receptors M1, M2 and M4. It is used to treat symptomatic Parkinsonism and extrapyramidal dysfunction caused by antipsychotic agents. |
Mechanism of Action: |
The mechanism of action is unknown. It is thought that Procyclidine acts by blocking central cholinergic receptors, and thus balancing cholinergic and dopaminergic activity in the basal ganglia. Many of its effects are due to its pharmacologic similarities with atropine. Procyclidine exerts an antispasmodic effect on smooth muscle, and may produce ...
show more » |
Protein binding: | Approximately 100% bound to albumin. |
Toxicity: | LD50=60 mg/kg (IV in mice) |
Affected organisms: | Humans and other mammals |
Drug interaction: |
|
---|